Health-related quality of life, cognitive screening, and functional status in a randomized phase III trial (EF-14) of tumor treating fields with temozolomide compared to temozolomide alone in newly diagnosed glioblastoma
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Health-related quality of life, cognitive screening, and functional status in a randomized phase III trial (EF-14) of tumor treating fields with temozolomide compared to temozolomide alone in newly diagnosed glioblastoma
Authors
Keywords
Glioblastoma, Health-related quality of life (HRQoL), Cognition, Tumor treating fields, Temozolomide, EF-14
Journal
JOURNAL OF NEURO-ONCOLOGY
Volume 135, Issue 3, Pages 545-552
Publisher
Springer Nature
Online
2017-08-28
DOI
10.1007/s11060-017-2601-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Maintenance Therapy With Tumor-Treating Fields Plus Temozolomide vs Temozolomide Alone for Glioblastoma
- (2015) Roger Stupp et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Tumor Treating Fields Perturb the Localization of Septins and Cause Aberrant Mitotic Exit
- (2015) Nidhi Gera et al. PLoS One
- Mitotic Spindle Disruption by Alternating Electric Fields Leads to Improper Chromosome Segregation and Mitotic Catastrophe in Cancer Cells
- (2015) Moshe Giladi et al. Scientific Reports
- The epidemiology of glioma in adults: a "state of the science" review
- (2014) Q. T. Ostrom et al. NEURO-ONCOLOGY
- Pregabalin versus Pramipexole for Restless Legs Syndrome
- (2014) NEW ENGLAND JOURNAL OF MEDICINE
- Prospective evaluation of health-related quality of life in patients with glioblastoma multiforme treated on a phase II trial of hypofractionated IMRT with temozolomide
- (2013) Krishna Reddy et al. JOURNAL OF NEURO-ONCOLOGY
- NovoTTF-100A versus physician’s choice chemotherapy in recurrent glioblastoma: A randomised phase III trial of a novel treatment modality
- (2012) Roger Stupp et al. EUROPEAN JOURNAL OF CANCER
- Minimal clinically meaningful differences for the EORTC QLQ-C30 and EORTC QLQ-BN20 scales in brain cancer patients
- (2011) J. Maringwa et al. ANNALS OF ONCOLOGY
- Impact of therapy on quality of life, neurocognitive function and their correlates in glioblastoma multiforme: a review
- (2011) Roger Henriksson et al. JOURNAL OF NEURO-ONCOLOGY
- International Cognition and Cancer Task Force recommendations to harmonise studies of cognitive function in patients with cancer
- (2011) Jeffrey S Wefel et al. LANCET ONCOLOGY
- Neurocognitive function: an emerging surrogate endpoint for neuro-oncology trials
- (2011) M. Weller NEURO-ONCOLOGY
- An international validation study of the EORTC brain cancer module (EORTC QLQ-BN20) for assessing health-related quality of life and symptoms in brain cancer patients
- (2010) Martin J.B. Taphoorn et al. EUROPEAN JOURNAL OF CANCER
- Health related quality of life and cognitive status in patients with glioblastoma multiforme receiving escalating doses of conformal three dimensional radiation on RTOG 98-03
- (2009) Benjamin W. Corn et al. JOURNAL OF NEURO-ONCOLOGY
- Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
- (2009) Roger Stupp et al. LANCET ONCOLOGY
- Detecting Dementia With the Mini-Mental State Examination in Highly Educated Individuals
- (2008) Sid E. O’Bryant et al. ARCHIVES OF NEUROLOGY
- Health-related quality of life in patients with high-grade glioma
- (2008) Jin-xiang Cheng et al. NEURO-ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search